Chen K, Li Q, Li Y, Jiang D, Chen L, Jiang J
Mol Med Rep. 2024; 30(5).
PMID: 39239742
PMC: 11411235.
DOI: 10.3892/mmr.2024.13324.
Li X, Li L, Wu J
J Transl Med. 2023; 21(1):105.
PMID: 36765401
PMC: 9912648.
DOI: 10.1186/s12967-023-03894-1.
Kong W, Yin G, Zheng S, Liu X, Zhu A, Yu P
Genes Dis. 2022; 9(5):1269-1280.
PMID: 35873034
PMC: 9293693.
DOI: 10.1016/j.gendis.2021.07.006.
Park J, Jin E, Hong J, Lee S, Sung J
Medicine (Baltimore). 2022; 100(48):e27773.
PMID: 35049170
PMC: 9191314.
DOI: 10.1097/MD.0000000000027773.
Xu J, Wen J, Li S, Shen X, You T, Huang Y
Front Genet. 2021; 12:690598.
PMID: 34290743
PMC: 8287335.
DOI: 10.3389/fgene.2021.690598.
Tetraspanins: Novel Molecular Regulators of Gastric Cancer.
Deng Y, Cai S, Shen J, Peng H
Front Oncol. 2021; 11:702510.
PMID: 34222025
PMC: 8250138.
DOI: 10.3389/fonc.2021.702510.
Integrative p53, micro-RNA and Cathepsin Protease Co-Regulatory Expression Networks in Cancer.
Soond S, Kozhevnikova M, Townsend P, Zamyatnin Jr A
Cancers (Basel). 2020; 12(11).
PMID: 33233599
PMC: 7699684.
DOI: 10.3390/cancers12113454.
Long Non-coding RNA in Gastrointestinal Cancer.
Martinez-Barriocanal A, Arango D, Dopeso H
Front Oncol. 2020; 10:38.
PMID: 32083000
PMC: 7005105.
DOI: 10.3389/fonc.2020.00038.
The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients.
El-Araby R, Khalifa M, Zoheiry M, Zahran M, Rady M, Ibrahim R
Cancer Gene Ther. 2019; 27(6):486-497.
PMID: 31316135
DOI: 10.1038/s41417-019-0123-9.
MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer.
Maimaitiming A, Wusiman A, Aimudula A, Kuerban X, Su P
Oncol Res. 2019; 28(1):13-19.
PMID: 30982494
PMC: 7851537.
DOI: 10.3727/096504019X15519249902838.
Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.
Moya L, Meijer J, Schubert S, Matin F, Batra J
Int J Mol Sci. 2019; 20(5).
PMID: 30845775
PMC: 6429489.
DOI: 10.3390/ijms20051154.
microRNA-761 regulates glycogen synthase kinase 3β expression and promotes the proliferation and cell cycle of human gastric cancer cells.
Sun X, Hou H, Li K, Zheng M
Oncol Lett. 2018; 16(3):3459-3464.
PMID: 30127949
PMC: 6096227.
DOI: 10.3892/ol.2018.9133.
MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma.
Lu Z, Du M, Qian L, Zhang N, Gu J, Ding K
Onco Targets Ther. 2018; 11:1733-1741.
PMID: 29628766
PMC: 5877490.
DOI: 10.2147/OTT.S154464.
MicroRNA-152 regulates immune response via targeting B7-H1 in gastric carcinoma.
Wang Y, Wang D, Xie G, Yin Y, Zhao E, Tao K
Oncotarget. 2017; 8(17):28125-28134.
PMID: 28427226
PMC: 5438636.
DOI: 10.18632/oncotarget.15924.
Long Non-coding RNAs in Gastric Cancer: A True Relationship or miR Chance?.
Mavridis K
Dig Dis Sci. 2017; 62(11):2952-2954.
PMID: 28315027
DOI: 10.1007/s10620-017-4537-7.
Long Noncoding RNA PVT1 Acts as a "Sponge" to Inhibit microRNA-152 in Gastric Cancer Cells.
Li T, Meng X, Yang W
Dig Dis Sci. 2017; 62(11):3021-3028.
PMID: 28258379
DOI: 10.1007/s10620-017-4508-z.
CD151-mediated adhesion is crucial to osteosarcoma pulmonary metastasis.
Wang Z, Wang C, Zhou Z, Sun M, Zhou C, Chen J
Oncotarget. 2016; 7(37):60623-60638.
PMID: 27556355
PMC: 5312406.
DOI: 10.18632/oncotarget.11380.
miR-152 as a tumor suppressor microRNA: Target recognition and regulation in cancer.
Liu X, Li J, Qin F, Dai S
Oncol Lett. 2016; 11(6):3911-3916.
PMID: 27313716
PMC: 4888271.
DOI: 10.3892/ol.2016.4509.
Cell-free microRNAs in blood and other body fluids, as cancer biomarkers.
Ortiz-Quintero B
Cell Prolif. 2016; 49(3):281-303.
PMID: 27218664
PMC: 6496612.
DOI: 10.1111/cpr.12262.
Ubiquitin-Conjugating Enzyme E2T is an Independent Prognostic Factor and Promotes Gastric Cancer Progression.
Yu H, Xiang P, Pan Q, Huang Y, Xie N, Zhu W
Tumour Biol. 2016; 37(9):11723-11732.
PMID: 27020591
DOI: 10.1007/s13277-016-5020-3.